3D Text Encoding and TEI
Journal of the Text Encoding Initiative · 2024 · Issue 18
DOI: 10.4000/165rx ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Text Encoding Initiative, 2024. Verfasst von Jun Ogawa und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This paper explores the integration of 3D technology in digital humanities, focusing on the increasing enthusiasm for 3D research practices in the field. It discusses the adoption of 3D methods in research and the challenge of advancing the field, particularly the representation of “text” in 3D models, such as inscriptions. The paper suggests integrating TEI (Text Encoding Initiative) markup with 3D space to represent rich text information in three-dimensional space, using inscriptions as a case study. It outlines methods for 3D text encoding, leveraging TEI, especially using the EpiDoc schema and extending it for 3D applications. The paper emphasizes the advantage of adopting the genetic edition–like markup using , to document spatial data, particularly 3D coordinates, to fully represent text in 3D space. The paper contributes to the discussion on encoding textual data in 3D environments, proposing adjustments to existing schemas to accommodate 3D information and highlighting the need for further development in this emerging field.
Zitieren
APA
Ogawa, J., Nagasaki, K., Ohmukai, I., & Kitamoto, A. (2024). 3D Text Encoding and TEI. Journal of the Text Encoding Initiative, Issue 18. https://doi.org/10.4000/165rx
Vancouver
Ogawa J, Nagasaki K, Ohmukai I, Kitamoto A. 3D Text Encoding and TEI. Journal of the Text Encoding Initiative. 2024;Issue 18. doi:10.4000/165rx
BibTeX
@article{Ogawa2024,
author = {Ogawa, Jun and Nagasaki, Kiyonori and Ohmukai, Ikki and Kitamoto, Asanobu},
title = {3D Text Encoding and TEI},
journal = {Journal of the Text Encoding Initiative},
year = {2024},
volume = {Issue 18},
doi = {10.4000/165rx}
}
EUVIMED